Updated
Updated · BuzzFeed · Jul 5
r/Futurology Draws 2,000 Comments on GLP-1s' 20-Year Impact
Updated
Updated · BuzzFeed · Jul 5

r/Futurology Draws 2,000 Comments on GLP-1s' 20-Year Impact

3 articles · Updated · BuzzFeed · Jul 5

Summary

  • More than 2,000 comments on an r/Futurology thread split between broad forecasts for GLP-1 drugs and first-person accounts of how Ozempic, Wegovy, Mounjaro and similar medicines are reshaping daily life.
  • Users predicted cheaper generics could widen access as semaglutide patents start expiring in some markets in 2026 and in the US around 2031-32, with one commenter estimating production costs near $3 a month.
  • Those forecasts centered on knock-on effects: obesity becoming more tied to poverty, thinner bodies losing status as a marker of discipline, and fast-food, alcohol and insurance industries pushing back as demand and spending fall.
  • Personal accounts described sharp drops in cravings, alcohol use and restaurant spending, alongside reports of diabetes remission, 40-pound weight loss and improved PCOS symptoms.
  • The same thread also highlighted risks from long-term use and uneven access, including weight regain, social and emotional side effects, ostracism of non-users and rare severe reactions such as pancreatitis.

Insights

When a cheap pill can make anyone thin, what will become the new, unattainable status symbol of the ultra-wealthy?
With GLP-1s threatening their profits, what 'tobacco playbook' tactics will the food and alcohol industries use to fight back?
As new drugs erase our cravings for food and alcohol, what essential parts of our humanity might we lose in the process?